Benzinga | Aug 6, 2020 05:33PM EDT

Mirati Therapeutics Q2 EPS $(1.89) Down From $(1.26) YoY

Mirati Therapeutics (NASDAQ:MRTX) reported quarterly losses of $(1.89) per share. This is a 50 percent decrease over losses of $(1.26) per share from the same period last year.